Customer Testimonials

At RegSmart, every assignment matters – whether large or small. Our team supports life science, pharma and medtech companies with tailored regulatory strategies that reduce risk and accelerate market access. From pharmacovigilance and scientific advice to clinical trial applications and combination products, we cover the full spectrum of regulatory challenges.

What sets us apart is our dedication to quality and long-term partnerships. Clients value our ability to simplify complex processes, ensure compliance and provide pragmatic solutions that work in practice. Whether navigating device regulations, medicinal product requirements or both, our mission is always to guide you with clarity and confidence.

On this page, you can explore customer testimonials and success stories. Discover how companies across the life science sector describe their experience with RegSmart – and why they continue to rely on our expertise for their most critical projects.

Customer Testimonial: Triomed AB – rethinking peritoneal dialysis

25.10.02

Groundbreaking methods for Peritoneal Dialysis require complex regulatory navigation, RegSmart supports Triomed in bringing new innovative solutions to the market.

Customer Testimonial: OnDosis – Revolutionizing how patients take their medicines

25.10.02

OnDosis is developing innovative solutions at the intersection of pharmaceuticals and medical devices. Their unique approach combines digital technology with medicinal products to create individualized treatments that improve patient outcomes.

Customer Testimonial: Gesynta Pharma – anti-inflammatory, pain-relieving pharmaceuticals

25.10.02

Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates to reduce harmful inflammation and pain. With a primary focus on endometriosis, a severely life-limiting disease that affects 10% of reproductive-aged women, their aim is to provide safe and effective treatments for several serious diseases.

Customer Testimonial: Abera Bioscience – the next generation mucosal vaccines

25.10.02

Abera Bioscience is an emerging vaccine company dedicated to developing groundbreaking vaccine candidates for mucosal administration. Their primary goal is to induce a strong mucosal immune response capable of blocking the transmission of infectious diseases, a critical need in global health.

Customer Testimonial: NanoEcho – rectal cancer diagnosis

24.07.08

NanoEcho is developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The solution is based on magnetomotive ultrasound – including iron oxide-based nanoparticles.